Re: Clinical Efficacy of Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease by Subgroups: Results from Two Large, Double-blind, Randomized, Placebo-controlled, Phase III Studies

被引：3
|
作者：
Kadioglu, Ates [1 ]
Boyuk, Abubekir [1 ]
Salabas, Emre [1 ]
机构：
[1] Istanbul Univ, Istanbul Fac Med, Sect Androl, Istanbul, Turkey
来源：
EUROPEAN UROLOGY | 2015年 / 68卷 / 05期
关键词：
QUESTIONNAIRE; SAFETY;
D O I：
10.1016/j.eururo.2015.07.067
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：908 / 909
页数：3
相关论文
共 50 条
  • [21] Efficacy and safety of oxycodone DETERx: results of a randomized, double-blind, placebo-controlled phase III study
    Kopecky, E.
    O'Connor, M.
    Varanasi, R.
    Saim, S.
    Fleming, A.
    JOURNAL OF PAIN, 2015, 16 (04): : S87 - S87
  • [22] Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease:: A randomized placebo-controlled double-blind clinical study
    Riedl, CR
    Sternig, P
    Langmann, F
    Galle, G
    Engelhardt, PF
    Vcelar, B
    Vorauer, K
    Wagner, A
    Katinger, H
    Pflüger, H
    JOURNAL OF UROLOGY, 2005, 173 (04): : 253 - 254
  • [23] Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease: A randomized placebo-controlled double-blind clinical study
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 219 - 219
  • [24] Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: A phase III, randomized, double-blind, placebo-controlled study
    Mizuno, Y.
    Kondo, T.
    MOVEMENT DISORDERS, 2012, 27 : S129 - S129
  • [25] Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results From a Randomized, Double-Blind, Placebo-Controlled, Phase III Study
    Kerscher, Martina
    Rzany, Berthold
    Prager, Welf
    Turnbull, Catriona
    Trevidic, Patrick
    Inglefield, Christopher
    DERMATOLOGIC SURGERY, 2015, 41 (10) : 1149 - 1157
  • [26] Efficacy and safety of itopride in functional dyspepsia: Results of two phase III multicentre, randomized, double-blind, placebo-controlled trials
    Talley, Nicholas J.
    Tack, Jan
    Ptak, Theadore
    Gupta, Rajendra
    Giguere, Monique
    GASTROENTEROLOGY, 2007, 132 (04) : A93 - A93
  • [27] EFFICACY OF LURASIDONE IN BIPOLAR DEPRESSION: RESULTS FROM TWO DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES
    Pikalov, A.
    Silva, R.
    Cucchiaro, J.
    Sarma, K.
    Hsu, J.
    Loebel, A.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2016, 50 : 132 - 132
  • [28] Liquid AbobotulinumtoxinA: Pooled Data From Two Double-Blind, Randomized, Placebo-Controlled Phase III Studies of Glabellar Line Treatment
    Hilton, Said
    Kestemont, Philippe
    Sattler, Gerhard
    Volteau, Magali
    Thompson, Catherine
    Andriopoulos, Bill
    Prygova, Inna
    Berg, Anna-Karin
    Ascher, Benjamin
    DERMATOLOGIC SURGERY, 2022, 48 (11) : 1198 - 1202
  • [29] Phase 2a, randomized, double-blind, placebo-controlled dose-ranging study of repeat doses of collagenase clostridium histolyticum for the treatment of edematous fibrosclerotic panniculopathy (cellulite)
    Goldman, Mitchel P.
    Sadick, Neil S.
    Young, Leroy
    Kaufman, Gregory J.
    Smith, Ted
    Tursi, James P.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB19 - AB19
  • [30] Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease:: A randomized placebo-controlled double-blind prospective clinical study
    Riedl, CR
    Sternig, P
    Gallé, G
    Langmann, F
    Vcelar, B
    Vorauer, K
    Wagner, A
    Katinger, H
    Pflüger, H
    EUROPEAN UROLOGY, 2005, 48 (04) : 656 - 661
12345